Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis

NCT00195676 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
1469
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Abbott